OPEN

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers.

Family, N., Maillet, E. L., Williams, L. T., Krediet, E., Carhart-Harris, R. L., Williams, T. M., ... & Raz, S. | Psychopharmacology | 18 December 2019

By OPEN|2020-01-07T14:05:34+01:0018 December 2019|Tags: E. Krediet, E. Maillet, L. Williams, N. Family, R. Carhart-Harris|

Decreased directed functional connectivity in the psychedelic state.

Barnett, L., Muthukumaraswamy, S. D., Carhart-Harris, R. L., & Seth, A. K. | NeuroImage | 17 December 2019

By OPEN|2020-01-16T15:53:50+01:0017 December 2019|Tags: A. Seth, L. Barnett, R. Carhart-Harris, S. Muthukumaraswamy|

Neurotrophic mechanisms of psychedelic therapy

Corne, R., & Mongeau, R. | Biologie aujourd'hui | 12 December 2019

By OPEN|2020-01-05T15:16:50+01:0012 December 2019|Tags: R. Corne, R. Mongeau|

Neuropharmacological modulation of the aberrant bodily self through psychedelics

Ho, J. T., Preller, K. H., & Lenggenhager, B. | Neuroscience & Biobehavioral Reviews | 6 December 2019

By OPEN|2020-01-16T15:47:23+01:006 December 2019|Tags: B. Lenggenhager, J. Ho, K. Preller|

Modulation of Social Cognition via Hallucinogens and “Entactogens”.

Preller, K. H., & Vollenweider, F. X. | Frontiers in Psychiatry | 3 December 2019

By OPEN|2020-01-07T14:12:37+01:003 December 2019|Tags: F. Vollenweider, K. Preller|

Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms.

dos Santos, R. G., & Hallak, J. E. C. | Neuroscience & Biobehavioral Reviews | 3 December 2019

By OPEN|2019-12-28T11:52:30+01:003 December 2019|Tags: J. Hallak, R. dos Santos|

Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Moreton, S. G., Szalla, L., Menzies, R. E., & Arena, A. F. | Psychopharmacology | 29 November 2019

By OPEN|2019-12-11T21:06:30+01:0029 November 2019|Tags: A. Arena, L. Szalla, R. Menzies, S. Moreton|

Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.

Andersson, M., & Kjellgren, A. | Harm reduction journal | 28 November 2019

By OPEN|2019-12-14T13:28:38+01:0028 November 2019|Tags: A. Kjellgren, M. Andersson|

Microdosing psychedelics: Motivations, subjective effects and harm reduction.

Lea, T., Amada, N., Jungaberle, H., Schecke, H., & Klein, M. | International Journal of Drug Policy | 25 November 2019

By OPEN|2019-12-14T13:18:35+01:0025 November 2019|Tags: H. Jungaberle, H. Schecke, M. Klein, N. Amanda, T. Lea|

Psilocybin-assisted therapy for depression: How do we advance the field?

Meikle, S. E., Liknaitzky, P., Rossell, S. L., Ross, M., Strauss, N., Thomas, N., ... & Castle, D. J. | Australian & New Zealand Journal of Psychiatry | 22 November 2019

By OPEN|2019-12-01T21:13:37+01:0022 November 2019|Tags: D. Castle, M. Ross, N. Strauss, N. Thomas, P. Liknaitzky, S. Meikle, S. Rossel|